The effect of magnesium treatment on the symptoms of mitral valve prolapse
Phase 3
- Conditions
- Mitral valve prolapse.Nonrheumatic mitral (valve) prolapseI34.1
- Registration Number
- IRCT20210403050827N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with mitral valve prolapse
Exclusion Criteria
Previous history of heart disease
Lack of access to tests
Lack of ECG interpretation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method